Monocyte phenotype and interleukin-1 production in patients undergoing haemodialysis.
The expression of MHC class II (HLA-DR) and complement receptor (CR1) surface molecules on CD 14+ monocytes were compared with the production of the monokine interleukin-1 beta (IL-1 beta) in patients with endstage renal disease undergoing maintenance haemodialysis (HD) with hollow fibre dialyzers containing cellulose (CE, n = 8) and polysulfone (PS, n = 7) membranes. Monocyte staining was performed in blood samples obtained at the beginning and after 3 h of HD. Analysis of surface marker expression was done by immunofluorescence staining and flow cytometry analysis. Specific fluorescence intensity for both CR1 and class II (HLA-DR) antigens was increased in patients treated with CE membranes at the beginning of a dialysis treatment when compared to healthy control values. Interestingly, after 3 h on dialysis a further increase was noted for CR1 complement receptor expression whereas the increased HLA-DR expression was no longer detectable. In contrast, specific fluorescence intensity for both antigens was not significantly different from controls, either before or after dialysis, in patients treated with PS. The capacity of peripheral blood mononuclear cells to produce IL-1 beta spontaneously in vitro in the two patient groups was found to parallel results on phenotypic expression of surface molecules. The present study demonstrates that functional signs of monocyte activation, as evidenced by an augmented IL-1 beta production, in some patients on long-term HD correlate with an increased expression of two functionally important monocyte surface marker molecules.
Schiller
B
B
Nephrology Department, Klinikum Grosshadern, FRG.
Ziegler-Heitbrock
H W
HW
Meyer
N
N
Schmidt
B
B
Blumenstein
M
M
D000328:Adult; D000368:Aged; D005260:Female; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis*; D007688:Kidneys, Artificial; D007958:Leukocyte Count; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D010641:Phenotype; D011951:Receptors, Complement / Q000378:metabolism; D017463:Receptors, Complement 3b; D006435:Renal Dialysis / Q000009:adverse effects*
D006684:HLA-DR Antigens; D007375:Interleukin-1; D008567:Membranes, Artificial; D011951:Receptors, Complement; D017463:Receptors, Complement 3b